These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 9871860

  • 1. The effects of unoprostone isopropyl 0.12% and timolol maleate 0.5% on diurnal intraocular pressure.
    Stewart WC, Stewart JA, Kapik BM.
    J Glaucoma; 1998 Dec; 7(6):388-94. PubMed ID: 9871860
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP, Mertz B, Yannoulis NC, Schwenninger C, Kapik B, Shams N, Unoprostone Monotherapy Study Group-EU.
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [Abstract] [Full Text] [Related]

  • 4. Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
    Day DG, Schacknow PN, Wand M, Sharpe ED, Stewart JA, Leech J, Stewart WC.
    Am J Ophthalmol; 2003 Feb; 135(2):138-43. PubMed ID: 12566015
    [Abstract] [Full Text] [Related]

  • 5. A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF2 alpha metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension.
    Nordmann JP, Rouland JF, Mertz BP.
    Curr Med Res Opin; 1999 Feb; 15(2):87-93. PubMed ID: 10494491
    [Abstract] [Full Text] [Related]

  • 6. The safety and efficacy of unoprostone 0.15% versus brimonidine 0.2%.
    Stewart WC, Stewart JA, Day DG, Jenkins J.
    Acta Ophthalmol Scand; 2004 Apr; 82(2):161-5. PubMed ID: 15043534
    [Abstract] [Full Text] [Related]

  • 7. Unoprostone as adjunctive therapy to timolol: a double masked randomised study versus brimonidine and dorzolamide.
    Hommer A, Kapik B, Shams N, Unoprostone Adjunctive Therapy Study Group.
    Br J Ophthalmol; 2003 May; 87(5):592-8. PubMed ID: 12714402
    [Abstract] [Full Text] [Related]

  • 8. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S, Mundorf TK, Stewart JA, Stewart WC.
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of timolol solution once daily versus timolol gel in treating elevated intraocular pressure.
    Stewart WC, Leland TM, Cate EA, Stewart JA.
    J Glaucoma; 1998 Dec; 7(6):402-7. PubMed ID: 9871862
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of timolol maleate versus brinzolamide each given twice daily added to travoprost in patients with ocular hypertension or primary open-angle glaucoma.
    Holló G, Chiselita D, Petkova N, Cvenkel B, Liehneova I, Izgi B, Berta A, Szaflik J, Turacli E, Stewart WC.
    Eur J Ophthalmol; 2006 Dec; 16(6):816-23. PubMed ID: 17191187
    [Abstract] [Full Text] [Related]

  • 12. [Long-term efficacy and safety of combined topical antiglaucoma therapy--timolol & unoprostone vs. betaxolol & unoprostone].
    Ohtake Y, Tanino T, Kimura I, Mashima Y, Oguchi Y.
    Nippon Ganka Gakkai Zasshi; 2004 Jan; 108(1):23-8. PubMed ID: 14969090
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The efficacy of unoprostone isopropyl as an adjunct to topical beta-blocker in patients with open angle glaucoma: a-6-month study.
    Leelachaikul Y, Euswas A.
    J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S100-4. PubMed ID: 16681060
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low incidence of iris pigmentation and eyelash changes in 2 randomized clinical trials with unoprostone isopropyl 0.15%.
    McCarey BE, Kapik BM, Kane FE, Unoprostone Monotherapy Study Group.
    Ophthalmology; 2004 Aug; 111(8):1480-8. PubMed ID: 15288975
    [Abstract] [Full Text] [Related]

  • 17. Additive efficacy of unoprostone isopropyl 0.12% (rescula) to latanoprost 0.005%.
    Stewart WC, Sharpe ED, Stewart JA, Holmes KT, Latham KE.
    Am J Ophthalmol; 2001 Mar; 131(3):339-44. PubMed ID: 11239866
    [Abstract] [Full Text] [Related]

  • 18. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH, Gungel H, Altan C, Pasaoglu IB, Sabanci S.
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [Abstract] [Full Text] [Related]

  • 19. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR, DuBiner HB, Carpenter SP, Khan B, VanDenburgh AM, Bimatoprost Circadian IOP Study Group.
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [Abstract] [Full Text] [Related]

  • 20. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.